Caspase-8 association with the focal adhesion complex promotes tumor cell migration and metastasis

Cancer Research

Volumn 69, Issue 9, 2009, Pages 3755-3763

  Barbero, Simone ^a   Mielgo, Ainhoa ^a   Torres, Vicente ^a   Teitz, Tal ^c   Shields, David J ^a   Mikolon, David ^a   Bogyo, Matthew ^d   Barilà, Daniela ^e   Lahti, Jill M ^d   Schlaepfer, David ^b   Stupack, Dwayne G ^a,b  

^a Department of Pathology ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN 2; CALPASTATIN; CASPASE 8; FOCAL ADHESION KINASE; INTEGRIN; MULTIPROTEIN COMPLEX;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CATALYSIS; CELL DISRUPTION; CELL MIGRATION; CONTROLLED STUDY; ENZYME SUBSTRATE; FOCAL ADHESION; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TUMOR RESISTANCE;

ANIMALS; CALCIUM-BINDING PROTEINS; CALPAIN; CASPASE 8; CELL LINE, TUMOR; CELL MOVEMENT; FOCAL ADHESION PROTEIN-TYROSINE KINASES; FOCAL ADHESIONS; HUMANS; LUNG NEOPLASMS; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; NEUROBLASTOMA; TALIN;

EID: 65949097277     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3937     Document Type: Article

References (53)

1. Takita J, Yang HW, Bessho F, et al. Absent or reduced expression of the caspase 8 gene occurs frequently in neuroblastoma, but not commonly in Ewing sarcoma or rhabdomyosarcoma. Med Pediatr Oncol 2000; 35: 541-3.
2. Takita J, Yang HW, Chen YY, et al. Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastoma. Oncogene 2001; 20: 4424-32.
3. Teitz T, Lahti JM, Kidd VJ. Aggressive childhood neuroblastomas do not express caspase-8:an important component of programmed cell death. J Mol Med 2001; 79: 428-36.
4. Teitz T, Wei T, Valentine MB, et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 2000; 6: 529-35.
5. Yang Q, Kiernan CM, Tian Y, et al. Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome. Clin Cancer Res 2007; 13: 3191-7.
6. Stupack DG, Teitz T, Potter MD, et al. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 2006; 439: 95-9.
7. Stupack DG, Puente XS, Boutsaboualoy S, Storgard CM, Cheresh DA. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J Cell Biol 2001; 155: 459-70.
8. Soung YH, Lee JW, Kim SY, et al. CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res 2005; 65: 815-21.
9. Kim HS, Lee JW, Soung YH, et al. Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 2003; 125: 708-15.
10. Hunter AM, LaCasse EC, Korneluk RG. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 2007; 12: 1543-68.
11. Hajra KM, Liu JR. Apoptosome dysfunction in human cancer. Apoptosis 2004; 9: 691-704.
12. Barnhart BC, Legembre P, Pietras E, Bubici C, Franzoso G, Peter ME. CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. EMBO J 2004; 23: 3175-85.
13. Gilot D, Serandour AL, Ilyin GP, et al. A role for caspase-8 and c-FLIPL in proliferation and cell-cycle progression of primary hepatocytes. Carcinogenesis 2005; 26: 2086-94.
14. Lemmers B, Salmena L, Bidere N, et al. Essential role for caspase-8 in Toll-like receptors and NFκB signaling. J Biol Chem 2007; 282: 7416-23.
15. Lens SM, Kataoka T, Fortner KA, et al. The caspase 8 inhibitor c-FLIP (L) modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes. Mol Cell Biol 2002; 22: 5419-33.
16. Salmena L, Hakem R. Caspase-8 deficiency in T cells leads to a lethal lymphoinfiltrative immune disorder. J Exp Med 2005; 202: 727-32.
17. Frisch SM. Caspase-8:fly or die. Cancer Res 2008; 68: 4491-3.
18. Senft J, Helfer B, Frisch SM. Caspase-8 interacts with the p85 subunit of phosphatidylinositol 3-kinase to regulate cell adhesion and motility. Cancer Res 2007; 67: 11505-9.
19. Helfer B, Boswell BC, Finlay D, et al. Caspase-8 promotes cell motility and calpain activity under nonapoptotic conditions. Cancer Res 2006; 66: 4273-8.
20. Barbero S, Barila D, Mielgo A, Stagni V, Clair K, Stupack D. Identification of a critical tyrosine residue in caspase 8 that promotes cell migration. J Biol Chem 2008; 283: 13031-4.
21. 1 integrins inhibit procaspase- 8 for mediating cell adhesion-mediated drug and radiation resistance in human leukemia cells. PLoS ONE 2007; 2: e269.
22. Stupack DG, Cheresh DA. Get a ligand, get a life:integrins, signaling and cell survival. J Cell Sci 2002; 115: 3729-38.
23. Mitra SK, Schlaepfer DD. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 2006; 18: 516-23.
24. Carragher NO, Westhoff MA, Fincham VJ, Schaller MD, Frame MC. A novel role for FAK as a proteasetargeting adaptor protein:regulation by p42 ERK and Src. Curr Biol 2003; 13: 1442-50.
25. Huttenlocher A, Palecek SP, Lu Q, et al. Regulation of cell migration by the calcium-dependent protease calpain. J Biol Chem 1997; 272: 32719-22.
26. Dourdin N, Bhatt AK, Dutt P, et al. Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts. J Biol Chem 2001; 276: 48382-8.
27. Hauck CR, Sieg DJ, Hsia DA, et al. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. Cancer Res 2001; 61: 7079-90.
28. Wrasidlo W, Mielgo A, Torres VA, et al. The marine lipopeptide somocystinamide A triggers apoptosis via caspase 8. Proc Natl Acad Sci U S A 2008; 105: 2313-8.
29. Kaplan KB, Bibbins KB, Swedlow JR, Arnaud M, Morgan DO, Varmus HE. Association of the aminoterminal half of c-Src with focal adhesions alters their properties and is regulated by phosphorylation of tyrosine 527. EMBO J 1994; 13: 4745-56.
30. Berger AB, Witte MD, Denault JB, et al. Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes. Mol Cell 2006; 23: 509-21.
31. Greenbaum D, Medzihradszky KF, Burlingame A, Bogyo M. Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. Chem Biol 2000; 7: 569-81.
32. Woo M, Hakem R, Soengas MS, et al. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev 1998; 12: 806-19.
33. Shikama Y, U M, Miyashita T, Yamada M. Comprehensive studies on subcellular localizations and cell death-inducing activities of eight GFP-tagged apoptosisrelated caspases. Exp Cell Res 2001; 264: 315-25.
34. Algeciras-Schimnich A, Shen L, Barnhart BC, Murmann AE, Burkhardt JK, Peter ME. Molecular ordering of the initial signaling events of CD95. Mol Cell Biol 2002; 22: 207-20.
35. 3 integrin cytoplasmic domain. J Biol Chem 2001; 276: 28164-70.
36. Calderwood DA. Talin controls integrin activation. Biochem Soc Trans 2004; 32: 434-7.
37. Franco SJ, Huttenlocher A. Regulating cell migration:calpains make the cut. J Cell Sci 2005; 118: 3829-38.
38. Calderwood DA, Tai V, Di Paolo G, De Camilli P, Ginsberg MH. Competition for talin results in transdominant inhibition of integrin activation. J Biol Chem 2004; 279: 28889-95.
39. Boatright KM, Deis C, Denault JB, Sutherlin DP, Salvesen GS. Activation of caspases-8 and -10 by FLIP (L). Biochem J 2004; 382: 651-7.
40. Besnault-Mascard L, Leprince C, Auffredou MT, et al. Caspase-8 sumoylation is associated with nuclear localization. Oncogene 2005; 24: 3268-73.
41. 380:a novel mechanism of apoptosis suppression. EMBO J 2006; 25: 1895-905.
42. Barglow KT, Cravatt BF. Activity-based protein profiling for the functional annotation of enzymes. Nat Methods 2007; 4: 822-7.
43. Franco SJ, Rodgers MA, Perrin BJ, et al. Calpainmediated proteolysis of talin regulates adhesion dynamics. Nat Cell Biol 2004; 6: 977-83.
44. Melloni E, Averna M, Stifanese R, et al. Association of calpastatin with inactive calpain:a novel mechanism to control the activation of the protease? J Biol Chem 2006; 281: 24945-54.
45. Wendt A, Thompson VF, Goll DE. Interaction of calpastatin with calpain:a review. Biol Chem 2004; 385: 465-72.
46. Friedrich P, Bozoky Z. Digestive versus regulatory proteases:on calpain action in vivo. Biol Chem 2005; 386: 609-12.
47. Su AI, Wiltshire T, Batalov S, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 2004; 101: 6062-7.
48. Kang TB, Ben-Moshe T, Varfolomeev EE, et al. Caspase-8 serves both apoptotic and nonapoptotic roles. J Immunol 2004; 173: 2976-84.
49. Varfolomeev EE, Schuchmann M, Luria V, et al. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3and is lethal prenatally. Immunity 1998; 9: 267-76.
50. Kinashi T. Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol 2005; 5: 546-59.
51. Su H, Bidere N, Zheng L, et al. Requirement for caspase-8 in NF-κB activation by antigen receptor. Science 2005; 307: 1465-8.
52. Hehlgans S, Haase M, Cordes N. Signalling via integrins:implications for cell survival and anticancer strategies. Biochim Biophys Acta 2007; 1775: 163-80.
53. Li ZW, Dalton WS. Tumor microenvironment and drug resistance in hematologic malignancies. Blood Rev 2006; 20: 333-42.